Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. (Q27851711)

From Wikidata

Jump to navigation Jump to search

scientific article

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

Language	Label	Description	Also known as
English	Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.	scientific article	Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

Statements

scholarly article

1 reference

13 November 2016

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. (English)

1 reference

13 November 2016

1 reference

based on heuristic

inferred from title

Federica Di Nicolantonio

4

0 references

Alberto Bardelli

8

0 references

object named as

Chong Sun

2

0 references

object named as

René Bernards

9

0 references

6

object named as

Davide Zecchin

0 references

author name string

Anirudh Prahallad

1

0 references

Sidong Huang

3

0 references

Ramon Salazar

5

0 references

Roderick L Beijersbergen

7

0 references

language of work or name

0 references

publication date

26 January 2012

0 references

1 reference

483

0 references

100-3

0 references

7387

0 references

BRAF mutations in hairy-cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations of the BRAF gene in human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The protein kinase complement of the human genome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR in melanoma: clinical significance and potential therapeutic target

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of epidermal growth factor receptor as a target of Cdc25A protein phosphatase

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The concept of synthetic lethality in the context of anticancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRAF mutations are associated with some histological types of papillary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRAFMutation in Metastatic Colorectal Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22281684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moyamoya disease and moyamoya syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNATURE10868

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NATURE10868

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Springer Nature article ID

10.1038/nature10868

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27851711&oldid=2033465724"